Rekvina Laboratories share news, announcements and annual reports
BSE: 526075Pharmaceuticals & BiotechnologySmall Cap
Rekvina Laboratories Ltd · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Nov 1993
Last close ₹57.00up ₹2.12 (3.86%)
Share price at the BSE close on 2 Nov 2026. Previous close ₹54.88.
2 Nov: open ₹55.15, high ₹57.00, low ₹52.14
- Under BSE's graded surveillance, stage 0, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹63 Cr4,235th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −139.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 4,260
Rekvina Laboratories board meetings
104 filed, newest first. Page 2 of 3.
May 2023
Feb 2023
6 Feb · Board meeting
Meeting on 13 Feb 2023: quarterly results
Nov 2022
14 Nov · Board meeting
7 Nov · Board meeting
Meeting on 14 Nov 2022: quarterly results
May 2022
26 May · Board meeting
20 May · Board meeting
Meeting on 26 May 2022: audited results
Feb 2022
1 Feb · Board meeting
Meeting on 7 Feb 2022: quarterly results
Nov 2021
11 Nov · Board meeting
3 Nov · Board meeting
Meeting on 11 Nov 2021: quarterly results
Aug 2021
12 Aug · Board meeting
6 Aug · Board meeting
Meeting on 12 Aug 2021: quarterly results
Jun 2021
15 Jun · Board meeting
Meeting on 21 Jun 2021: audited results
Feb 2021
5 Feb · Board meeting
Meeting on 12 Feb 2021: quarterly results
Nov 2020
6 Nov · Board meeting
Meeting on 13 Nov 2020: quarterly results
Sep 2020
9 Sep · Board meeting
Meeting on 15 Sep 2020: quarterly results
Jul 2020
Jun 2020
24 Jun · Board meeting
Meeting on 30 Jun 2020: audited results
Feb 2020
14 Feb · Board meeting
7 Feb · Board meeting
Meeting on 14 Feb 2020: quarterly results
Nov 2019
14 Nov · Board meeting
8 Nov · Board meeting
Meeting on 14 Nov 2019: quarterly results
Aug 2019
7 Aug · Board meeting
Meeting on 13 Aug 2019: quarterly results
May 2019
30 May · Board meeting
24 May · Board meeting
Meeting on 30 May 2019: audited results
Mar 2019
25 Mar · Board meeting
Feb 2019
14 Feb · Board meeting
8 Feb · Board meeting
Meeting on 14 Feb 2019: quarterly results
Nov 2018
5 Nov · Board meeting
Oct 2018
Aug 2018
13 Aug · Board meeting
May 2018
30 May · Board meeting